Tomer Keren

Tomer Keren is an accomplished professional in the field of biology and biotechnology, currently serving as the Head of Applied Biology at Picodya since November 2022. Prior to this role, Tomer held the position of VP R&D at Wilk (Biomilk TLV:BMLK) from July 2021 to August 2022, and previously served as CTO at Biogal Galed Labs, focusing on veterinary diagnostics from June 2013 to July 2021. Tomer's early career includes significant contributions at Alere Inc. from 2003 to May 2013 as an R&D Project Leader and R&D Scientist, where work involved the development of rapid point-of-care HIV nucleic acid tests. The professional journey began as a Technical Assistant at the Weizmann Institute of Science in 1997-1998. Tomer Keren earned a PhD in Biochemistry and Molecular Biology and a BSc in Clinical Nutrition from The Hebrew University of Jerusalem.